Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by susanuon Apr 04, 2015 5:22am
320 Views
Post# 23596424

Place your buys 1/2 cent above the gaps

Place your buys 1/2 cent above the gapsGaps on daily candlestick chart - from close to next days' range:
.215 - .22 Feb 19 & Feb 20
.35 - .355 Mar 5 & Mar 6
.44 - .445 Mar 6 & Mar 9
Twice the price has gone back to .445 - Mar 19 and Apr 2 with high buy amounts at .44

For those of you looking to buy more then place buys 1/2 cent above lower gap price...
e.g. .22, .355, .445 as to fill the gap needs only 1 share to trade there and I have seen
price drop to a low gap price fill one order then move up.

After all the shares sold at higher levels it is hard for me to believe that the .215 gap will fill
anytime soon but I can see the .35 gap filling especially if more share selling is done by
warrant holders.  The current double bottom at .445 may be the bottom but Elliottwave
rules would have Wave C correction go below. 

Some don't believe this type of technical analysis works on these microcaps but when one
trades in the millions of shares like this one then the human psychology kicks in and the
big traders will use fib retraces and gaps.

In my early days the huge drops would scare me out - now I just apportion my buys on a
stock like this that has a business in a highly lucrative field.  I keep a core position and I buy and sell traders at the gaps and fibs.  Until management shows me that their plan is not
feasible I will stay with it. 

Old people and drugs unfortunately seem to go together and here in B.C. - a retirement capital of Canada.  Vanc's list of approved drugs are the most popular.  We have a London Drugs in our small town and surrounding area of 8-10,000 people plus we have an independent drug store that had 2 pharmacists and a few sales clerks 15 or so years ago and now has 12 people working daily in it.  The next nearest town 15 miles away has the hospital and 4 drug
stores.  Further up the coast is another little town with a drug store.  For a population of
about 30,000 our pharmacists are kept busy. 

Cheers
Bullboard Posts